Trial Profile

A phase III trial assessing Non-Steroidal Nasal Spray for Pulmonary Fibrosis

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 09 Apr 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Non-steroidal COPD spray-Emphycorp (Primary)
Indications Pulmonary fibrosis
Focus Registrational; Therapeutic Use

Most Recent Events

07 Apr 2020 According to an EmphyCorp media release, Results from seventeen placebo-controlled human clinical trials including this trial were submitted to the FDA.
22 Aug 2019 New trial record
15 Aug 2019 According to an EmphyCorp media release, data from this trial is required for the NDA marketing application in patients with Pulmonary Fibrosis.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com